The present and future of pharmacotherapy of Alzheimer's disease: A comprehensive review
Alzheimer's disease (AD) is a generalized term used for the loss in memory and other
intellectual abilities on levels serious enough to interfere with daily life. It accounts for 60 …
intellectual abilities on levels serious enough to interfere with daily life. It accounts for 60 …
Drug candidates in clinical trials for Alzheimer's disease
SY Hung, WM Fu - Journal of biomedical science, 2017 - Springer
Alzheimer's disease (AD) is a major form of senile dementia, characterized by progressive
memory and neuronal loss combined with cognitive impairment. AD is the most common …
memory and neuronal loss combined with cognitive impairment. AD is the most common …
Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer's Disease: Preclinical to Clinical Trial Insights
K Nagori, KT Nakhate, K Yadav, Ajazuddin… - Future …, 2023 - mdpi.com
Alzheimer's disease (AD) is a progressive, multifactorial, and unremitting neurodegenerative
disease characterized by memory loss, personality changes, and cognitive impairment. It …
disease characterized by memory loss, personality changes, and cognitive impairment. It …
Can herbs provide a new generation of drugs for treating Alzheimer's disease?
TS Anekonda, PH Reddy - Brain research reviews, 2005 - Elsevier
The overall aim of this review is to discuss cellular mechanisms at work in the progression of
AD and current therapeutic strategies for treating AD, with a focus on the potential efficacy of …
AD and current therapeutic strategies for treating AD, with a focus on the potential efficacy of …
[PDF][PDF] Pathophysiology and management of Alzheimer's disease: An overview
Alzheimer's disease (AD) is the sixth-leading reason of fatality and is 70% present in all
cases of dementia. The global burden of AD is expected to accelerate from 26.6 million …
cases of dementia. The global burden of AD is expected to accelerate from 26.6 million …
Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs
Abstract Alzheimer's disease (AD), also called senile dementia, is the most common
neurological disorder. Around 50 million people, mostly of advanced age, are suffering from …
neurological disorder. Around 50 million people, mostly of advanced age, are suffering from …
Disease-modifying drugs in Alzheimer's disease
L Ghezzi, E Scarpini, D Galimberti - Drug design, development and …, 2013 - Taylor & Francis
Alzheimer's disease (AD) is an age-dependent neurodegenerative disorder and the most
common cause of dementia. The early stages of AD are characterized by short-term memory …
common cause of dementia. The early stages of AD are characterized by short-term memory …
[HTML][HTML] An update on the novel and approved drugs for Alzheimer disease
HA Alhazmi, M Albratty - Saudi Pharmaceutical Journal, 2022 - Elsevier
Introduction Given the severity of the condition and the increasing number of patients,
developing effective therapies for Alzheimer's disease has become a significant necessity …
developing effective therapies for Alzheimer's disease has become a significant necessity …
New treatment strategies for Alzheimer's disease: is there a hope?
I Aprahamian, F Stella, OV Forlenza - Indian Journal of Medical …, 2013 - journals.lww.com
Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disease, and
corresponds to the most common cause of dementia worldwide. Although not fully …
corresponds to the most common cause of dementia worldwide. Although not fully …
[PDF][PDF] An update on drug treatment options of Alzheimer's disease
M Allgaier, C Allgaier - Front Biosci (Landmark Ed), 2014 - academia.edu
Introduction 3. Mechanisms underlying dementia of the Alzheimer type 4. Drugs approved
for the treatment of Alzheimer's disease 4.1. Acetylcholine esterase inhibitors 4.1. 1 …
for the treatment of Alzheimer's disease 4.1. Acetylcholine esterase inhibitors 4.1. 1 …